• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Nov 30;15(1):10438.
doi: 10.1038/s41467-024-54762-5. TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication

Maria Gonzalez-Orozco[SUP] 1 [/SUP], Hsiang-Chi Tseng[SUP] 2 [/SUP], Adam Hage[SUP] 1 [/SUP], Hongjie Xia[SUP] 3 [/SUP], Padmanava Behera[SUP] 2 [/SUP], Kazi Afreen[SUP] 2 [/SUP], Yoatzin Peñaflor-Tellez[SUP] 2 [/SUP], Maria I Giraldo[SUP] 1 [/SUP], Matthew Huante[SUP] 1 [/SUP], Lucinda Puebla-Clark[SUP] 4 [/SUP], Sarah van Tol[SUP] 1 [/SUP], Abby Odle[SUP] 2 [/SUP], Matthew Crown[SUP] 5 [/SUP], Natalia Teruel[SUP] 6 [/SUP], Thomas R Shelite[SUP] 4 [/SUP], Joaquin Moreno-Contreras[SUP] 2 [/SUP], Kaori Terasaki[SUP] 1 [/SUP], Shinji Makino[SUP] 1 [/SUP], Vineet Menachery[SUP] 1 [/SUP], Mark Endsley[SUP] 1 [/SUP], Janice J Endsley[SUP] 1 [/SUP], Rafael J Najmanovich[SUP] 6 [/SUP], Matthew Bashton[SUP] 5 [/SUP], Robin Stephens[SUP] 4 7 [/SUP], Pei-Yong Shi[SUP] 3 [/SUP], Xuping Xie[SUP] 3 [/SUP], Alexander N Freiberg[SUP] 8 [/SUP], Ricardo Rajsbaum[SUP] 9 10 [/SUP]



Affiliations
Abstract

SARS-CoV-2 is a highly transmissible virus that causes COVID-19 disease. Mechanisms of viral pathogenesis include excessive inflammation and viral-induced cell death, resulting in tissue damage. Here we show that the host E3-ubiquitin ligase TRIM7 acts as an inhibitor of apoptosis and SARS-CoV-2 replication via ubiquitination of the viral membrane (M) protein. Trim7[SUP]-/-[/SUP] mice exhibit increased pathology and virus titers associated with epithelial apoptosis and dysregulated immune responses. Mechanistically, TRIM7 ubiquitinates M on K14, which protects cells from cell death. Longitudinal SARS-CoV-2 sequence analysis from infected patients reveal that mutations on M-K14 appeared in circulating variants during the pandemic. The relevance of these mutations was tested in a mouse model. A recombinant M-K14/K15R virus shows reduced viral replication, consistent with the role of K15 in virus assembly, and increased levels of apoptosis associated with the loss of ubiquitination on K14. TRIM7 antiviral activity requires caspase-6 inhibition, linking apoptosis with viral replication and pathology.


 
Back
Top Bottom